AML100 boosts battery life by up to 20x with innovative system-level approach to always-on power reduction
The AML100 boosts battery life by up to 20x with an innovative system-level approach to always-on power reduction
BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics
The agreement combines industry-leading technologies, enabling single cell selection and genome sequencing, and supports the development of intact tissue sample analysis
NTx Awarded Grant to Develop Novel Manufacturing Technologies for Improved Global Access to mRNA Vaccines and Therapeutics
NTx has received a grant from the Bill & Melinda Gates Foundation to develop new production approaches to lower the cost and improve access to mRNA vaccines and therapeutics for low- and middle-income countries
GelSight Expands its Board of Directors to Guide Transformation into Tactile Intelligence Platform Company
MAKO and Magic Leap founder Rony Abovitz and experienced executive and investor Elliot Katzman will help shape GelSight’s strategy and reach
Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
First-in-human trial is now open for enrollment for EBT-101, a CRISPR-based therapeutic being developed as a potential functional cure for people living with HIV
Beyond Imagination and GelSight Announce Pilot to Pair State-of-the-art Tactile Sensing With Cutting-edge Telepresence Robotics
Beyond Imagination and GelSight have initiated a pilot to study the feasibility of using Beyond Imagination’s humanoid robotic technology to remotely operate GelSight’s tactile sensors.
NUBURU Secures Fresh Funding and Appoints COO and VP of Global Sales to Accelerate Expansion
Additional growth capital brings NUBURU’s valuation to approximately $350M and executive appointments will accelerate commercialization of its blue laser technology
InterVenn Promotes Klaus Lindpaintner to InterVenn Distinguished Scientist; Appoints Tillman Pearce as Chief Medical Officer
Klaus has served so far as the company’s Chief Medical and Scientific Officer and will now focus on serving as InterVenn’s scientific alliance ambassador to the global glycobiology constituency.
NTx Appoints Former Chairman and CEO of Allstate Corporation Edward Liddy to Board of Directors
Mr. Liddy brings over 30 years of executive leadership, IPO and private equity experience, and board involvement with Abbott Laboratories, AbbVie, and Boeing to help guide NTx’s commercialization efforts
Albemarle and 6K Sign Joint Development Agreement to Develop Novel Lithium Battery Materials
Albemarle to invest in 6K and sponsor development of UniMelt® system for advanced, sustainable materials production